[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Safaa Ali\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":42},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":4,"eligibilityCriteria":14,"healthyVolunteers":15,"sex":16,"minAge":4,"maxAge":4,"enrollmentInfo":17,"targetDuration":20,"studyType":21,"phases":4,"briefSummary":22,"conditions":23,"keywords":26,"overallStatus":30,"whyStopped":4,"lastUpdateSubmitDate":31,"lastUpdatePostDateStruct":32,"startDateStruct":35,"completionDateStruct":37,"leadSponsor":39,"locationsCount":4},"100601641","role-of-sf3b1-mutation-in-assessment-of-acute-and-chronic-lymphatic-leukemia-100601641",false,"NCT07113132","Role of SF3B1 Mutation in Assessment of Acute and Chronic Lymphatic Leukemia","Inclusion Criteria:\n\n* Patients with acute lymphocytic leukemia or chronic lymphocytic leukemia of both genders at any age.\n\nExclusion Criteria:\n\n* Patients with any other type of malignancies",true,"ALL",{"count":18,"type":19},84,"ESTIMATED","6 Months","OBSERVATIONAL","aim of the work\n\n1. To evaluate the presence of SF3B1-K700E mutation in acute lymphoblastic leukemia and chronic lymphocytic leukemia.\n2. To determine the correlation between the presence of SF3B1-K700E mutation with other laboratory findings.",[24,25],"Acute Lymphoblastic Leukemia ALL","Chronic Lymphocytic Leukemia (CLL)",[27,28,29],"sf3b1 mutation","all","cll","NOT_YET_RECRUITING","2025-08-06",{"date":33,"type":34},"2025-08-08","ACTUAL",{"date":36,"type":19},"2025-08-01",{"date":38,"type":19},"2027-07-01",{"name":40,"class":41},"Safaa Ali","OTHER",""]